Regeneron Pharmaceuticals
In Joel Greenblatt's portfolio · Gotham Asset Management
Ticker REGN
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Gotham Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2026 | Add 3% | 82,846 | 0.2% |
| Q4 2025 | Reduce 5% | 80,271 | 0.2% |
| Q3 2025 | Add 212% | 84,230 | 0.2% |
| Q1 2022 | Reduce 36% | 15,100 | 0.3% |
| Q4 2021 | Add 338% | 23,664 | 0.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.